WO2006031179A1 - Processus de preparation de phtalimide - Google Patents
Processus de preparation de phtalimide Download PDFInfo
- Publication number
- WO2006031179A1 WO2006031179A1 PCT/SE2005/001315 SE2005001315W WO2006031179A1 WO 2006031179 A1 WO2006031179 A1 WO 2006031179A1 SE 2005001315 W SE2005001315 W SE 2005001315W WO 2006031179 A1 WO2006031179 A1 WO 2006031179A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- process according
- phtalimide
- dione
- isoindole
- acetyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Definitions
- the present invention is directed to a new process for the synthesis of (S)-glycidyl phtalimide as well as to new intermediates in the process.
- a further method to synthesise (S)-glycidyl phtalimide is described in WO 99/24393 and comprises the steps of reacting (S)-epichlorohydrin with phtalimide in DMF and subsequently reacting the product of said reaction step with tBuONa in ethanol.
- One object of the present invention was to develop a process for the production of (S)- glycidyl phtalimide that is more suitable for large-scale production.
- the present invention is directed to a new process for the production of (S)-glycidyl phthalimide in high purity and with retained stereochemistry.
- the process according to the present invention comprises the steps of: a) Reacting (R)-3-Chloro-l,2-propanediol and a phthalimide salt b) Reacting the product of step a) with trimethylorthoacetate and an essentially water- free acid c) Reacting the product of step b) with acetyl halogenide d) Reacting the product of step c) in a basic ester hydrolysis.
- the present invention is also directed to the intermediates (S)-2-(2-Methoxy-2-methyl- [l,3]dioxolane-4-ylmethyl)-isoindole-l,3-dione, (S)-2-(2-Acetoxy-3-bromo-propyl)- isoindole-l,3-dione, (S)-2-(2-Acetoxy-3-chloro-propyl)-isoindole-l,3-dione and (S)-2-(2- Acetoxy-3-iodo-propyl)-isoindole-l,3-dione.
- the process according to the present invention comprises the steps of: a) Reacting (R)-3-Chloro-l,2-propanediol and a phthalimide salt b) Reacting the product of step a) with trimethylorthoacetate and a water-free acid c) Reacting the product of step b) with acetyl halogenide d) Reacting the product of step c) in a basic ester hydrolysis.
- the reaction in step a) takes place in an alcohol solvent such as methanol or polyethylene glycol.
- the reaction is carried out at from 6O 0 C to 80°C for 5 hours to 20 hours.
- the phtalimide salt is potassium phtalimide or sodium phtalimide.
- 1.0 to 1.4 equivalents of phtalimide salt is used.
- 1.1 to 1.3 equivalents of phtalimide salt is used.
- 1.2 equivalents of phtalimide salt is used.
- step b) is carried out in an aprotic solvent, such as methylene chloride or acetonitrile.
- the reaction is carried out at from 0°C to room temperature for 1 hour to 6 hours.
- the essentially water-free acid may be trifluoroacetic acid (TFA), methanesulfonic acid, p-toluene sulfonic acid or pyridinium p- toluenesulfonate (PPTS).
- the essentially water-free acid is trifluoroacetic acid.
- the wording "essentially water-free" means that the acid used in the process according to the present invention may contain up to 2% water.
- step c) is carried out in an aprotic solvent, such as toluene, methylene chloride or acetonitrile.
- the acetyl halogenide is selected from acetyl chloride, acetyl iodide or acetyl bromide. In one embodiment, the acetyl halogenide is acetyl bromide.
- the reaction is carried at from O 0 C to room temperature for 1 hour to 4 hours.
- step d) is carried out in a polar solvent, such as methanol, tetrahydrofuran (THF) or dioxane.
- a polar solvent such as methanol, tetrahydrofuran (THF) or dioxane.
- the basic ester hydrolysis can be performed using a base such as potassium carbonate (K 2 CO 3 ), sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium tert-butoxide (tBuONa) or potassium tert- butoxide (tBuOK).
- the base potassium carbonate (K 2 CO 3 ) is used.
- the reaction is carried out at from O 0 C to room temperature for 1 hour to 4 hours.
- Step b) (S)-2-(2-Methoxy-2-methyl-[l,3]dioxolane-4-ylmethyl)-isoindole-l,3-dione
- the crude (S)-2-(2,3-Dihydroxy-propyl)-isoindole-l,3-dione from step a) was suspended in toluene (50 mL) followed by addition of trimethylorthoacetate (1.5 eq, 8.5 mL, 66.5 mmoles) and trifluoroacetic acid (0.2 eq, 0.67 mL, 8.9 mmoles).
- Step c) (S)-2-(2-Acetoxy-3-bromo-propyl)-isoindole-l,3-dione
- the crude (S)-2-(2-Methoxy-2-methyl-[l,3]dioxolane-4-ylmethyl)-isoindole-l,3-dione from step b) was dissolved in toluene (50 mL) and the mixture was cooled to 0°C before the addition of acetyl bromide (1.3 eq, 4.3 mL, 57.6 mmoles). After 1 h of reaction at ambient temperature and inert atmosphere, the mixture was concentrated at reduced pressure at 40 0 C.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402200-0 | 2004-09-13 | ||
SE0402200A SE0402200D0 (sv) | 2004-09-13 | 2004-09-13 | New process II |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006031179A1 true WO2006031179A1 (fr) | 2006-03-23 |
Family
ID=33157527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2005/001315 WO2006031179A1 (fr) | 2004-09-13 | 2005-09-12 | Processus de preparation de phtalimide |
Country Status (2)
Country | Link |
---|---|
SE (1) | SE0402200D0 (fr) |
WO (1) | WO2006031179A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103145698A (zh) * | 2013-03-01 | 2013-06-12 | 江西同和药业有限责任公司 | 一种利伐沙班中间体的制备方法及利伐沙班的新合成方法 |
CN104569213A (zh) * | 2015-01-23 | 2015-04-29 | 江苏正大清江制药有限公司 | 高效液相色谱法测定(s)-(+)-n-(2,3-乙氧基丙基)邻苯二甲酰亚胺含量的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5244901A (en) * | 1991-06-27 | 1993-09-14 | Synthelabo | 4-pyrimidinecarboxamide derivatives, their preparation and their application in therapy |
WO1999024393A1 (fr) * | 1997-11-07 | 1999-05-20 | Pharmacia & Upjohn Company | Procede de production d'oxazolidinones |
EP1403267A1 (fr) * | 2002-09-25 | 2004-03-31 | Daiso Co., Ltd. | Procédé de préparation de glycidylphthalimide |
-
2004
- 2004-09-13 SE SE0402200A patent/SE0402200D0/xx unknown
-
2005
- 2005-09-12 WO PCT/SE2005/001315 patent/WO2006031179A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5244901A (en) * | 1991-06-27 | 1993-09-14 | Synthelabo | 4-pyrimidinecarboxamide derivatives, their preparation and their application in therapy |
WO1999024393A1 (fr) * | 1997-11-07 | 1999-05-20 | Pharmacia & Upjohn Company | Procede de production d'oxazolidinones |
EP1403267A1 (fr) * | 2002-09-25 | 2004-03-31 | Daiso Co., Ltd. | Procédé de préparation de glycidylphthalimide |
Non-Patent Citations (2)
Title |
---|
KOLB H.C. AND SHARPLESS K.B.: "A Simplified Procedure for the Stereospecific Transformation of 1,2-Diols into Epoxides", TETRAHEDRON, vol. 48, 1992, pages 10515 - 10530, XP002993847 * |
KOLB H.C. ET AL: "Catalytic Asymmetric Dihydroxylation", CHEM. REV., vol. 94, 1994, pages 2483 - 2547, XP002248191 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103145698A (zh) * | 2013-03-01 | 2013-06-12 | 江西同和药业有限责任公司 | 一种利伐沙班中间体的制备方法及利伐沙班的新合成方法 |
CN104569213A (zh) * | 2015-01-23 | 2015-04-29 | 江苏正大清江制药有限公司 | 高效液相色谱法测定(s)-(+)-n-(2,3-乙氧基丙基)邻苯二甲酰亚胺含量的方法 |
Also Published As
Publication number | Publication date |
---|---|
SE0402200D0 (sv) | 2004-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1340549C (fr) | Methode pour preparer des derives de la sphingosine | |
US20030212292A1 (en) | Shortened synthesis of 3,3-diarylpropylamine derivatives | |
US20080221340A1 (en) | Process for the Production of Nebivolol | |
WO2006031179A1 (fr) | Processus de preparation de phtalimide | |
JP5301676B2 (ja) | (3s,4s)−4−((r)−2−(ベンジルオキシ)トリデシル)−3−ヘキシル−2−オキセタノンの製造方法及びそれに用いられる新規な中間体 | |
Adamo et al. | An Improved Resolution Of 2-Methyl Piperidine And Its Use in The Synthesis Of Homochiral Trans-2, 6-Dialkyl Piperidines | |
EP3498695A1 (fr) | Procédé de synthèse d'acide 3- (difluorométhyl)-1-méthyl-1 h-pyrazole-4-carboxylique, et ses intermédiaires | |
WO1999052855A1 (fr) | Procede permettant de preparer des derives chiraux (s) de 1-propylamine 2,3-disubstituee | |
US4408063A (en) | Preparation of epihalohydrin enantiomers | |
CN108727323B (zh) | 一种氮杂环卡宾催化合成三氟甲基取代高异黄酮类化合物的方法 | |
KR0125155B1 (ko) | 프탈이미드 화합물 및 그 제조방법 | |
US4922009A (en) | Stereoconvergent process for preparing optically active carboxylic acids | |
CN114805168B (zh) | 吡咯啉酮类化合物及其合成方法 | |
US4346042A (en) | Preparation of epihalohydrin enantiomers | |
CN113135865B (zh) | 一种制备n-苯基-3-(苯并三氮唑-1-基)丙酰胺的方法 | |
KR100332703B1 (ko) | 광학활성을갖는(s)-3,4-에폭시부티르산염의제조방법 | |
CN109574894B (zh) | 一种n-(3-(二甲基胺基)-3-丙硫酰基)-取代的苯甲酰胺的(i)合成方法 | |
JPH0637449B2 (ja) | 光学活性アテノロール及びその中間体の製法 | |
KR0162703B1 (ko) | 마취성 진통 작용을 갖는 수펜타닐(n-4-메톡시메틸-1-[2-(티에닐)에틸]-4-피페리디닐-n-페닐 프로판아미드) 및 그의 n-아릴알킬-4-피페리돈 중간체를 제조하는 방법 | |
KR20070082985A (ko) | 오셀타미비르의 제조방법 | |
KR101087631B1 (ko) | 스핀고신의 제조방법 | |
JP3283959B2 (ja) | D−ビオチン中間体およびその製造法 | |
KR100311949B1 (ko) | 1-[(사이클로펜트-3-엔-1-일)메틸]-5-에틸-6-(3,5-다이메틸벤조일)-2,4-피리미딘다이온의제조방법 | |
KR790001648B1 (ko) | 트리메톡시 벤질 피페라지노 에탄올 유도체의 제조방법 | |
CN117088830A (zh) | 一种2-氨基-2-(呋喃-3-基)乙酸类化合物的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |